Abstract
Although the dopamine transporter (DAT) is the primary site of action for cocaine, and the dopamine system is known to mediate the reinforcing effects of cocaine, the dopaminergic variations underlying individual differences in cocaine self-administration behaviors are not fully understood. Recent advances in the application of economic principles to operant tasks in rodents have allowed for the within-subject, within-session determination of both consummatory and appetitive responding for reinforcers. Here we combined a behavioral economics approach with cocaine self-administration and ex vivo voltammetric recording of dopamine signaling in the core of the nucleus accumbens of rats to determine the relationship between dopamine signaling and discrete aspects of cocaine taking and seeking. We found neither dopamine release or uptake tracked individual differences in cocaine consumption or the reinforcing efficacy of cocaine. Cocaine potency at the DAT was correlated with reinforcing efficacy, but was not related to cocaine consumption. Further, we introduce a novel analysis that determines perseverative responding within the same procedure, and find that cocaine potency at the DAT also tracks differences in perseverative responding. Together, we demonstrate that cocaine effects at the DAT determine the reinforcing efficacy of cocaine, and perseverative responding for sub-threshold doses of cocaine that do not maintain responding when presented in isolation. Surprisingly, we find that variations in cocaine potency do not account for differences in cocaine consumption, suggesting that satiation for cocaine is determined by other targets or mechanisms. Finally, we outline a novel approach for relating drug–target interactions and potency to discrete motivational states during a single self-administration session.
Similar content being viewed by others
Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ahmed SH, Koob GF (2005). Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 180: 473–490.
Bentzley BS, Fender KM, Aston-Jones G (2013). The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures. Psychopharmacology (Berl) 226: 113–125.
Bentzley BS, Jhou TC, Aston-Jones G (2014). Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rat. Proc Natl Acad Sci USA 111: 11822–11827.
Bock R, Shin JH, Kaplan AR, Dobi A, Markey E, Kramer PF et al (2013). Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use. Nat Neurosci. 16: 632–638.
Cahill E, Pascoli V, Trifilieff P, Savoldi D, Kappès V, Lüscher C et al (2014). D1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responses. Mol Psychiatry. 19: 1295–1304.
Calipari ES, Ferris MJ, Salahpour A, Caron MG, Jones SR (2013). Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun 4: 2720.
Calipari ES, Ferris MJ, Siciliano CA, Jones SR (2015b). Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate. ACS Chem Neurosci 6: 155–162.
Calipari ES, Ferris MJ, Zimmer BA, Roberts DC, Jones SR (2013). Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology 38: 2385–2392.
Calipari ES, Ferris MJ, Siciliano CA, Zimmer BA, Jones SR (2014). Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter. J Pharmacol Exp Ther 349: 192–198.
Calipari ES, Siciliano CA, Zimmer BA, Jones SR (2015a). Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking. Neuropsychopharmacology 40: 728–735.
Callahan PM, De La Garza R 2nd, Cunningham KA (1997). Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav. 57: 601–607.
Chen N, Reith ME (2007). Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J Neurochem. 101: 377–388.
Chen R, Han DD, Gu HH (2005). A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. J Neurochem. 94: 352–359.
Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S et al (2006). Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci USA 103: 9333–9338.
Christensen C, Silberberg A, Hursh S, Huntsberry M, Riley A. (2008). Essential value of cocaine and food in rats: tests of the exponential model of demand. Psychopharmacology 198: 221–229.
Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y et al (2008). Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454: 118–121.
Cunningham KA, Callahan PM (1991). Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berl) 104: 177–180.
Ehrich JM, Phillips PE, Chavkin C (2014). Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens. Neuropsychopharmacology 39: 3036–3048.
Ferris MJ, Calipari ES, Yorgason JT, Jones SR (2013). Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem Neurosci 4: 693–703.
Hermans A, Keithley RB, Kita JM, Sombers LA, Wightman RM (2008). Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem 80: 4040–4048.
Hoffman AF, Spivak CE, Lupica CR (2016). Enhanced dopamine release by dopamine transport inhibitors described by a restricted diffusion model and fast-scan cyclic voltammetry. ACS Chem Neurosci 7: 700–709.
Hong WC, Amara SG (2010). Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem. 285: 32616–32626.
Hotz G, Helm-Estabrooks N (1995). Perseveration. Part I: a review. Brain Inj 9: 151–159.
Huang X, Gu HH, Zhan CG (2009). Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations. J Phys Chem B. 113: 15057–15066.
Hursh SR, Silberberg A (2008). Economic demand and essentialvalue. Psychol Rev 115: 186–198.
Hursh SR, Winger G (1995). Normalized demand for drugs and other reinforcers. J Exp Anal Behav 64: 373–384.
Kawa AB, Bentzley BS, Robinson TE (2016). Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior. Psychopharmacology (Berl) 233: 3587–3602.
Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J et al (2014). Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biol Psychiatry. 76: 802–809.
Lack CM, Jones SR, Roberts DC (2008). Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats. Psychopharmacology (Berl) 195: 517–525.
Loland CJ, Grånäs C, Javitch JA, Gether U (2004). Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding. J Biol Chem. 279: 3228–3238.
McGinnis MM, Siciliano CA, Jones SR (2016). Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter. J Neurochem 138: 821–829.
Melia KF, Spealman RD (1991). Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J Pharmacol Exp Ther. 258: 626–632.
Norman AB, Norman MK, Tabet MR, Tsibulsky VL, Pesce AJ (2011). Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration. Synapse 65: 404–411.
Oleson EB, Richardson JM, Roberts DC (2011). A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid. Psychopharmacology (Berl) 214: 567–577.
Oleson EB, Roberts DC (2009). Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake. Neuropsychopharmacology 34: 796–804.
Oleson EB, Roberts DC (2012). Cocaine self-administration in rats: threshold procedures. Methods Mol Biol. 829: 303–319.
Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R (1982). Plasma cocaine concentrations during cocaine paste smoking. Life Sci. 30: 731–738.
Pan HT, Menacherry S, Justice JB Jr. (1991). Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats. J Neurochem 56: 1299–1306.
Pascoli V, Besnard A, Hervé D, Pagès C, Heck N, Girault JA et al (2011). Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. Biol Psychiatry 69: 218–227.
Pascoli V, Terrier J, Espallergues J, Valjent E, O'Connor EC, Lüscher C (2014). Contrasting forms of cocaine-evoked plasticity control components of relapse. Nature 509: 459–464.
Paterson NE, Markou A (2003). Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14: 2229–2232.
Peoples LL, Kravitz AV, Lynch KG, Cavanaugh DJ (2007). Accumbal neurons that are activated during cocaine self-administration are spared from inhibitory effects of repeated cocaine self-administration. Neuropsychopharmacology 32: 1141–1158.
Peoples LL, Lynch KG, Lesnock J, Gangadhar N (2004). Accumbal neural responses during the initiation and maintenance of intravenous cocaine self-administration. J Neurophysiol 91: 314–323.
Pettit HO, Justice JB Jr (1989). Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav. 34: 899–904.
Porter-Stransky KA, Bentzley BS, Aston-Jones G (2015). Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil. Addict Biol (e-pub ahead of print).
Richardson NR, Roberts DC (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1–11.
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219–1223.
Roberts DC, Corcoran ME, Fibiger HC (1977). On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6: 615–620.
Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E et al (2008). Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105: 4405–4410.
Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2014a). Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci 34: 5575–5582.
Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2015a). Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. ACS Chem Neurosci 6: 27–36.
Siciliano CA, Calipari ES, Jones SR (2014b). Amphetamine potency varies with dopamine uptake rate across striatal subregions. J Neurochem. 131: 348–355.
Siciliano CA, Ferris MJ, Jones SR (2015b). Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. Eur J Neurosci. 42: 2091–2096.
Siciliano A, Fordahl SC, Jones SR (2016). Cocaine self-administration produces long-lasting alterations in dopamine transporter responses to cocaine. J Neurosci 36: 7807–7816.
Stuber GD, Roitman MF, Phillips PE, Carelli RM, Wightman RM (2005a). Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology 30: 853–863.
Stuber GD, Wightman RM, Carelli RM (2005b). Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron 46: 661–669.
Suto N, Wise RA (2011). Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core. J Neurosci 31: 17917–17922.
Thomsen M, Han DD, Gu HH, Caine SB (2009). Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331: 204–211.
Tsibulsky VL, Norman AB (1999). Satiety threshold: a quantitative model of maintained cocaine self-administration. Brain Res. 839: 85–93.
Venton BJ, Seipel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P et al (2006). Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26: 3206–3209.
Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN et al (1997). Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386: 827–830.
Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JB Jr. (1995). Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 120: 10–20.
Wood DM, Emmett-Oglesby MW (1989). Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 33: 453–457.
Yorgason JT, España RA, Jones SR (2011). Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158–164..
Zimmer BA, Oleson EB, Roberts DCS (2012). The motivation to self-administer is increased after a history of spiking brain levels of cocaine. Neuropsychopharmacology 37: 1901–1910.
Zittel-Lazarini A, Cador M, Ahmed SH (2007). A critical transition in cocaine self-administration: behavioral and neurobiological implications. Psychopharmacology (Berl) 192: 337–346.
Acknowledgements
This work was funded by NIH grants R01 DA021325, R01 DA030161, P50 DA006634 (SRJ) and F31 DA037710, T32 AA007565, F32 MH111216 (CAS).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Rights and permissions
About this article
Cite this article
Siciliano, C., Jones, S. Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration. Neuropsychopharmacol 42, 1893–1904 (2017). https://doi.org/10.1038/npp.2017.24
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2017.24
This article is cited by
-
Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking
Neuropsychopharmacology (2024)
-
Ibrutinib as a potential therapeutic for cocaine use disorder
Translational Psychiatry (2021)
-
Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction
Neuropsychopharmacology (2021)
-
Effects of the monoamine stabilizer, (-)-OSU6162, on cocaine-induced locomotion and conditioned place preference in mice
Naunyn-Schmiedeberg's Archives of Pharmacology (2021)
-
Granulocyte colony-stimulating factor (G-CSF) enhances cocaine effects in the nucleus accumbens via a dopamine release–based mechanism
Psychopharmacology (2021)